Europe oral rehydration salt (ORS) market size was valued at USD 2,446.08 million in 2018, growing at a CAGR of 5.1% during the forecast period of 2019–2026.
Oral rehydration salt (ORS) is a glucose-based salt solution used in oral rehydration therapy to prevent or treat dehydration from diarrhea in individuals. In many developing countries, diarrhea is one of the most common causes of mortality in infants and the mortality can be reduced to a great extent using ORS. The prevalence of diarrhea in developed regions such as Europe is continuously decreasing. However, the demand for sports ORS preparations is constantly increasing for retaining and recovering water and salt loss due to heavy exercises.
Moreover, unpredictable immigration in the European countries due to various natural and unsustainable conditions is expected to increase the demand for ORS. For instance, immigrants from developing countries such as Africa and Syria in Europe have almost doubled in 2015. Availability of different dosage forms can fulfill different demands from a variety of consumer. For instance, ORS tablet and liquid are used by sports persons and travelers, as they are more convenient and easier for consumption.
Penetration of OTC products in many European developing countries is witnessing considerable growth. Additionally, increasing purchasing power, growing awareness among population regarding advantages of ORS, and rising availability of all forms of ORS are expected to fuel the ORS market growth. For instance, O.R.S from Clinova has started launching its product in different European countries.
Apart from this, increasing consumption of alcohol among the young population and gaining importance of ORS to handle hangover are likely to propel the ORS market growth in the coming years. Small countries with a lack of investment in the healthcare sector are expected to offer a lucrative opportunity for the ORS manufacturer. Moreover, the strong presence of the target customer base for various dosage forms is expected to fuel the market growth. For instance, many ORS tablet manufacturing companies in Europe are promoting ORS tablet for athletes.
| Study Period | 2020-2032 | CAGR | 5.1% |
| Historical Period | 2020-2022 | Forecast Period | 2024-2032 |
| Base Year | 2023 | Base Year Market Size | USD XX Billion |
| Forecast Year | 2032 | Forecast Year Market Size | USD XX Billion |
In Europe oral rehydration salt (ORS) market, U.K is generating the highest revenue in the forecast period. Though Europe has a greater number of developed countries in the world, Diarrhea is still the leading cause of death in children younger than 5 years. Rapidly developing companies to offer ORS in order to lower the death count related to Diarrhea have driven the demand for ORS. Many companies are offering ORS in various forms such as powder, tablet, and liquid, these are used in various marketing strategies to spread awareness regarding ORS throughout the region.
Developing tourism industry is one of the factors driving the demand for ORS in this region. Liquid dosage form of ORS is more convenient for handling and consumption mostly for the person who is traveling. For instance, Clinova’s strategy of associating with sports teams or individuals is making a positive impact on revenue. Furthermore, the rising practice of different kinds of sports activities such as football, athletics, cycling, etc., and growing awareness among the population regarding Diarrhea induced death are boosting the demand in European countries.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
For a better understanding of the Europe oral rehydration salt (ORS) market, we have segmented the market by type, and application.
By Type, the market is segmented into tablets, powder, capsules and others. Powder is accounting for the largest market share in the forecast period. To make essential drugs available through most appropriate technology and simplest way at an affordable price, United Nations International Children's Emergency Fund (UNICEF) and World Health Organization (WHO) are collectively emphasizing on producing ORS in powder form for diarrhea treatment. However, continuously reducing cases of diarrhea in European countries have shifted the focus of the manufacturers towards other ORS preparations used to replace water and salt losses due to heavy exercise.
The Covid-19 pandemic has significantly affected the total tile market, with demand remaining subdued for 6 months in 2020. End-use industries such as construction, manufacturing, and chemical, among others, have seen substantial expansion in the market. For example, the United States has a well-established building industry. Until 2019, the construction industry contributed over USD 2 trillion to the American economy. Due to the pandemic, the figure fell to USD 1.3 trillion in 2020. As a result, the expansion of all related industries has been impeded. Several ongoing projects have been canceled or postponed.
The usage of fluorosilicic acid for aluminum production in the automotive sector had dropped by more than 20%. The demand for aluminum in this industry is directly related to the entire vehicle output. As a result, the acid market experienced the same influence on demand. This was caused by, among other things, the entire and partial suspension of manufacturing facilities, limited transportation of commodities, a prohibition on import and export activities, and the closure of showrooms.
The global fluorosilicic acid market research study emphasizes possible recovery scenarios during the forecast period. Fluorosilicic acid is created as a byproduct of the production of phosphate fertilizers and from phosphate rock that includes fluoride and silica and is processed with sulfuric acid. It is a dry salt additive that must be dissolved in a solution before it can be added to water. Rising ground and surface water contamination raise the need for water treatment, which raises the demand for fluorosilicic acid.
